Deciduous Therapeutics

Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove...

Healthcare
San Francisco, CA, United States
11 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$26.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Deciduous Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required